General Information. The sole shareholder company Particle Measuring Systems S.r.l. (hereafter "PMS" or the "Company"), is a company incorporated and registered in Italy with registered office in ▇▇▇▇▇▇▇▇ (▇▇), ▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇. 34, which has a permanent establishment in Belgium and Denmark. The Company is a wholly owned subsidiary of Spectris Plc (Holding Company of the Spectris Group) through Spectris Group Holding Limited, based in London, (UK). The Company carries out the design, development activities and marketing of products and services for environmental monitoring within the industry, mainly pharmaceutical, electronics, and life science industry, and sales activities of consumable products for industrial microbiology. It, through offering a wide range of tools, enables its customers to monitor environmental quality and weigh fact-based decisions in order to improve the productivity of their processes and meet the regulatory requirements to which they are subjected. The instruments marketed by the Company are used globally in particle monitoring activities. Specifically, the Company offers products and services related to cleanroom monitoring, aero dispersion research, parenteral sampling, filter and in-line testing in purified water and process chemicals, point-of-use monitoring of inert gases, aerial sampling of microbial activity, and compressed gas monitoring. The Company's reference clients are represented by major multinational companies operating in the pharmaceutical industry, including in particular: GlaxoSmithKline Biologicals, Patheon Italia by Thermo ▇▇▇▇▇▇▇ Scientific, Merck Serono, BSP Pharmaceuticals, Les Laboratoires Medis, Boehringer Ingelheim Animal Health France with regard to the production of completely sterile drugs and medical devices with very low risk of contamination. Moreover, the Company works on behalf of public institutions and international bodies that, as part of their functions, need to monitor the dispersion of particles in the environment and the degree of environmental pollution/alteration, as they are responsible for monitoring, prevention and public health protection roles. Finally, the Company provides support services to many hospital companies for clean-room management. The Company's target market is the European market, with a predominant focus on Italy. Specifically, the Italian market is managed directly from Italy, while the European market is managed mainly through permanent establishments based in Belgium and Denmark. The statutory audit of the financial statements is handled by the Audit firm RSM Società di Revisione e Organizzazione Contabile S.p.A., appointed with shareholder’s meeting minutes dated 27 June 2022 which approved the Financial Statements as at 31 dec 2021
Appears in 1 contract
Sources: Financial Statements
General Information. The sole shareholder company Particle Measuring Systems S.r.l. (hereafter "PMS" or the "Company"), is a company incorporated and registered in Italy with registered office in ▇▇▇▇▇▇▇▇ (▇▇), ▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇no. 34, which has a permanent establishment in Belgium and Denmark. The Company is a wholly owned subsidiary of Spectris Plc (Holding Company of the Spectris Group) through Spectris Spec- tris Group Holding Limited, based in LondonEgham, (UK). The Company carries out the design, development activities and marketing of products and services for environmental environ- mental monitoring within the industry, mainly pharmaceutical, electronics, and life science industry, and sales activities activ- ities of consumable products for industrial microbiology. It, through offering a wide range of tools, enables its customers cus- tomers to monitor environmental quality and weigh fact-based decisions in order to improve the productivity of their processes and meet the regulatory requirements to which they are subjected. The instruments marketed by the Company are used globally in particle monitoring activities. Specifically, the Company offers products and services related to cleanroom monitoring, aero dispersion research, parenteral sampling, filter and in-line testing in purified water and process chemicals, point-of-use monitoring of inert gases, aerial sampling of microbial activity, and compressed gas monitoring. The Company's reference clients are represented by major multinational companies operating in the pharmaceutical industry, including in particular: GlaxoSmithKline Biologicals, Patheon Italia by Thermo ▇▇▇▇▇▇▇ Scientific, Merck Serono, BSP Pharmaceuticals, Les Laboratoires Medis, and Boehringer Ingelheim Animal Health France with regard re- gard to the production of completely sterile drugs and medical devices with very low risk of contamination. Moreover, the Company works on behalf of public institutions and international bodies that, as part of their functions, need to monitor the dispersion of particles in the environment and the degree of environmental pollution/alteration, as they are responsible for monitoring, prevention and public health protection roles. Finally, the Company provides support services to many hospital companies for clean-room management. The Company's target market is the European market, with a predominant focus on Italy. Specifically, the Italian market is managed directly from Italy, while the European market is managed mainly through permanent establishments establish- ments based in Belgium and Denmark. The statutory audit of the financial statements is handled by the Audit firm RSM Società di Revisione e Organizzazione Or- ganizzazione Contabile S.p.A., appointed with shareholder’s meeting minutes dated 27 June 2022 which approved the Financial Statements as at 31 dec 2021minutes.
Appears in 1 contract
Sources: Financial Statements